DEMONSTRATION OF INTERLEUKIN-6 IN MIDDLE-EAR EFFUSIONS

被引:2
|
作者
YELLON, RF
LEONARD, G
MARUCHA, P
SIDMAN, J
CARPENTER, R
BURLESON, J
CARLSON, J
KREUTZER, D
机构
[1] UNIV CONNECTICUT HLTH CTR, DEPT PATHOL, FARMINGTON, CT 06030 USA
[2] STAMFORD HOSP, DEPT SURG, STAMFORD, CT 06904 USA
[3] UNIV CONNECTICUT, CTR HLTH, DEPT SURG, DIV OTOLARYNGOL, FARMINGTON, CT 06032 USA
[4] UNIV CONNECTICUT, CTR HLTH, DEPT BEHAV SCI, FARMINGTON, CT 06032 USA
关键词
D O I
暂无
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
In response to infection in the middle ear, inflammatory cells produce cytokines-potent regulators and mediators of the immune response. In an earlier study, we demonstrated that levels of the cytokine interleukin 1 were higher in middle-ear effusions from younger children, while levels of the cytokine tumor necrosis factor were higher in middle-ear effusions from older children and in those requiring tympanostomy on multiple occasions. In this study, we evaluated middle-ear effusions for levels of the cytokine interleukin 6. Activities of interleukin 6 include stimulation of bone erosion and production of antibodies and fever. Using an enzyme-linked immunosorbent assay system, significant levels of interleukin 6 (>0.2 pg/mL) were found in 14 (36%) of 39 middle-ear effusions from 25 children with otitis media with effusion. The mean (+/-SE) level of interleukin 6 in middle-ear effusions was 173.9+/-74.7 pg/mg of total protein. Like interleukin 1, levels of interleukin 6 were higher in younger children. Tumor necrosis factor may be an important regulator of the local immune response in the middle-ear cleft during persistence of otitis media with effusion, while interleukin 1 and interleukin 6 may be important regulators during the early stages of otitis media with effusion.
引用
收藏
页码:745 / 748
页数:4
相关论文
共 50 条
  • [1] MIDDLE-EAR EFFUSIONS
    HILDMANN, H
    HILDMANN, A
    ALLERGOLOGIE, 1991, 14 (06) : 218 - 223
  • [2] CLEARANCE OF MIDDLE-EAR EFFUSIONS AND MIDDLE-EAR PRESSURES
    SADE, J
    HALEVY, A
    HADAS, E
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1976, 85 (02): : 58 - 62
  • [3] VALIDATION OF LOSS OF MIDDLE-EAR REFLECTIONS WITH MIDDLE-EAR EFFUSIONS
    HORNBERGER, B
    MONTGOMERY, JR
    CLINICAL RESEARCH, 1993, 41 (04): : A732 - A732
  • [4] PROSTAGLANDINS IN MIDDLE-EAR EFFUSIONS
    BERNSTEIN, JM
    OKAZAKI, T
    REISMAN, RE
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 1976, 102 (05) : 257 - 258
  • [5] PATHOGENESIS OF MIDDLE-EAR EFFUSIONS
    PAPARELLA, MM
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1976, 85 (02): : 63 - 65
  • [6] BACTERIOLOGY OF MIDDLE-EAR EFFUSIONS
    CALHOUN, KH
    NORRIS, WB
    HOKANSON, JA
    STIERNBERG, CM
    QUINN, FB
    SOUTHERN MEDICAL JOURNAL, 1988, 81 (03) : 332 - 336
  • [7] MIDDLE-EAR EFFUSIONS IN NEONATES
    BALKANY, TJ
    BERMAN, SA
    SIMMONS, MA
    JAFEK, BW
    LARYNGOSCOPE, 1978, 88 (03): : 398 - 405
  • [8] ATOPY AND MIDDLE-EAR EFFUSIONS
    DELAGUARDIA, J
    JOHNSONS, B
    GOYCOOLEA, M
    PAPARELLA, M
    JUHN, S
    BLUMENTHAL, M
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1987, 79 (01) : 259 - 259
  • [9] MIDDLE-EAR EFFUSIONS - DEFINITIONS
    MAWSON, SR
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1976, 85 (02): : 12 - 14
  • [10] SURFACTANT IN MIDDLE-EAR EFFUSIONS
    GRACE, A
    KWOK, P
    HAWKE, M
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 1987, 96 (04) : 336 - 340